title: Reply to Dr. Kotze's and Dr. Yamamoto's letter.
authors: IBD Unit, Complesso Integrato Columbus, Catholic University, Rome, Italy. Electronic address: alearmuzzi@yahoo.com.
authors: Alessandro
authors: A
authors: Armuzzi
authors: Carla
authors: C
authors: Felice
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use*; D003424:Crohn Disease / Q000517:prevention & control*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D000069285:Infliximab; D008297:Male
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D000069285:Infliximab; D001379:Azathioprine